Minimizing Sexual Dysfunction in BPH Surgery

Overview

Journal Curr Sex Health Rep

Publisher Springer

Specialty Reproductive Medicine

Date 2019 Aug 31

PMID 31467497

Citations 10

Authors

Joon Yau Leong

Amir S Patel

Ranjith Ramasamy

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: To review the prevalence and risks of sexual dysfunction associated with current treatment options for benign prostatic hyperplasia and to characterize techniques and methods to manage postoperative sexual dysfunction-related side effects.

Recent Findings: Current surgical therapies available for the treatment of benign prostatic hyperplasia are associated with a substantial risk of both ejaculatory and erectile function. However, many of the novel minimally invasive treatment alternatives have demonstrated the ability to preserve postoperative sexual function to a better degree, all while providing significant relief of lower urinary tract symptoms in an equally safe and efficacious manner.

Summary: Benign prostatic hyperplasia remains a highly prevalent disease among the aging population. While surgical treatments are often necessary to relieve bothersome urinary symptoms, these procedures are associated with an increased risk of sexual dysfunction. As such, there has been an increased interest in the development of minimally invasive therapies, such as the UroLift®, Rezum®, and Aquablation®, with the hopes of achieving similar symptomatic relief while maintaining sexual function. Aside from reporting lower rates of sexual dysfunction, these procedures have also demonstrated comparable safety, durability, and efficacy to current gold standard therapies. Some procedures can even be performed in an outpatient setting, avoiding the need for general anesthesia altogether. Overall, an individualized, shared decision-making approach is necessary to determine the ideal treatment option for each patient.

Citing Articles

Evaluating the Impact of Benign Prostatic Hyperplasia Surgical Treatments on Sexual Health.

Kaltsas A, Kratiras Z, Zachariou A, Dimitriadis F, Sofikitis N, Chrisofos M Biomedicines. 2024; 12(1).

PMID: 38255215 PMC: 10813562. DOI: 10.3390/biomedicines12010110.

Patients' Perspectives on Attributes While Choosing Minimally Invasive Surgery for Benign Prostatic Hyperplasia Procedures: Experience from Men Undergoing Water Vapor Thermal Therapy.

Rojanasarot S, Cutone B, Durand K, Zorn K, Chughtai B, Bhojani N J Endourol. 2023; 37(5):575-580.

PMID: 36762936 PMC: 10210213. DOI: 10.1089/end.2022.0607.

Inhibitory effects of macrofungi on experimental benign prostatic hyperplasia in rats.

Onoja R, Ihedioha J, Shoyinka S, Ezema A, Emejuo N, Mgbeahuruike A Iran J Basic Med Sci. 2023; 26(1):121-127.

PMID: 36594056 PMC: 9790059. DOI: 10.22038/IJBMS.2022.64972.14309.

Ejaculation Sparing Thulium Laser Enucleation of the Prostate: An Observational Prospective Study.

Trama F, Di Lauro G, Illiano E, Iacono F, Romis L, Mordente S J Clin Med. 2022; 11(21).

PMID: 36362593 PMC: 9658552. DOI: 10.3390/jcm11216365.

An Evaluation of Sexual Function in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men Treated with the Temporarily Implanted Nitinol Device.

Elterman D, Alshak M, Martinez Diaz S, Shore N, Gittleman M, Motola J J Endourol. 2022; 37(1):74-79.

PMID: 36070450 PMC: 9810348. DOI: 10.1089/end.2022.0226.

References

Donovan J, Peters T, Neal D, Brookes S, Gujral S, Chacko K . A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study. J Urol. 2000; 164(1):65-70. View

COURSEY J, Morey A, McAninch J, Summerton D, Secrest C, White P . Erectile function after anterior urethroplasty. J Urol. 2001; 166(6):2273-6. View

MEBUST W, HOLTGREWE H, Cockett A, Peters P . Transurethral prostatectomy: immediate and postoperative complications. a cooperative study of 13 participating institutions evaluating 3,885 patients. 1989. J Urol. 2002; 167(2 Pt 2):999-1003; discussion 1004. View

Cimentepe E, Unsal A, Saglam R . Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months. J Endourol. 2003; 17(2):103-7. DOI: 10.1089/08927790360587432. View

Rosen R, Altwein J, Boyle P, Kirby R, Lukacs B, Meuleman E . Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003; 44(6):637-49. DOI: 10.1016/j.eururo.2003.08.015. View

Hill B, Belville W, Bruskewitz R, Issa M, Perez-Marrero R, Roehrborn C . Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol. 2004; 171(6 Pt 1):2336-40. DOI: 10.1097/01.ju.0000127761.87421.a0. View

Taher A . Erectile dysfunction after transurethral resection of the prostate: incidence and risk factors. World J Urol. 2004; 22(6):457-60. DOI: 10.1007/s00345-004-0449-1. View

Briganti A, Naspro R, Gallina A, Salonia A, Vavassori I, Hurle R . Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol. 2006; 175(5):1817-21. DOI: 10.1016/S0022-5347(05)00983-3. View

Roehrborn C . Benign prostatic hyperplasia: an overview. Rev Urol. 2006; 7 Suppl 9:S3-S14. PMC: 1477638. View

10.

Meng F, Gao B, Fu Q, Chen J, Liu Y, Shi B . Change of sexual function in patients before and after Ho:YAG laser enucleation of the prostate. J Androl. 2006; 28(2):259-61. DOI: 10.2164/jandrol.106.000372. View

11.

Muntener M, Aellig S, Kuettel R, Gehrlach C, Sulser T, Strebel R . Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome. Eur Urol. 2007; 52(2):510-5. DOI: 10.1016/j.eururo.2007.01.088. View

12.

Ponholzer A, Madersbacher S . Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment. Int J Impot Res. 2007; 19(6):544-50. DOI: 10.1038/sj.ijir.3901578. View

13.

Kuntz R, Lehrich K, Ahyai S . Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2007; 53(1):160-6. DOI: 10.1016/j.eururo.2007.08.036. View

14.

Kavoussi P, Hermans M . Maintenance of erectile function after photoselective vaporization of the prostate for obstructive benign prostatic hyperplasia. J Sex Med. 2008; 5(11):2669-71. DOI: 10.1111/j.1743-6109.2008.00978.x. View

15.

Bruyere F, Puichaud A, Pereira H, Faivre dArcier B, Rouanet A, Floch A . Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol. 2010; 58(2):207-11. DOI: 10.1016/j.eururo.2010.04.027. View

16.

Frieben R, Lin H, Hinh P, Berardinelli F, Canfield S, Wang R . The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review. Asian J Androl. 2010; 12(4):500-8. PMC: 3739367. DOI: 10.1038/aja.2010.33. View

17.

Chen Q, Zhang L, Fan Q, Zhou J, Peng Y, Wang Z . Bipolar transurethral resection in saline vs traditional monopolar resection of the prostate: results of a randomized trial with a 2-year follow-up. BJU Int. 2010; 106(9):1339-43. DOI: 10.1111/j.1464-410X.2010.09401.x. View

18.

Spaliviero M, Strom K, Gu X, Araki M, Culkin D, Wong C . Does Greenlight HPS(™) laser photoselective vaporization prostatectomy affect sexual function?. J Endourol. 2010; 24(12):2051-7. DOI: 10.1089/end.2010.0296. View

19.

Bruyere F . The relationship between photoselective vaporization of the prostate and sexual function. Curr Urol Rep. 2011; 12(4):261-4. DOI: 10.1007/s11934-011-0199-8. View

20.

Zong H, Peng X, Yang C, Zhang Y . The impact of transurethral procedures for benign prostate hyperplasia on male sexual function: a meta-analysis. J Androl. 2011; 33(3):427-34. DOI: 10.2164/jandrol.111.013490. View